| Unique ID issued by UMIN | UMIN000054582 |
|---|---|
| Receipt number | R000062370 |
| Scientific Title | Frequency and severity of postoperative bleeding after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis receiving continuous single antithrombotic drugs (A multicenter prospective study) |
| Date of disclosure of the study information | 2024/07/01 |
| Last modified on | 2025/07/16 15:14:55 |
Frequency and severity of postoperative bleeding after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis receiving continuous single antithrombotic drugs (A multicenter prospective study)
A multicenter prospective study of the impact of single antithrombotic drug continuation on postoperative bleeding after PTGBD
Frequency and severity of postoperative bleeding after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis receiving continuous single antithrombotic drugs (A multicenter prospective study)
A multicenter prospective study of the impact of single antithrombotic drug continuation on postoperative bleeding after PTGBD
| Japan |
Patients with indication of PTGBD for acute cholecystitis
| Gastroenterology |
Others
NO
Prospective assessment of bleeding rates after PTGBD in patients with acute cholecystitis receiving continuous single antithrombotic drug
Safety
Not applicable
Frequency and severity of bleeding after PTGBD in patients with acute cholecystitis according to the use of the antithrombotic drug
1. The factors associated with whole bleeding and severe bleeding after PTGBD
2. The frequency of postoperative bleeding for each antithrombotic drug and comparison of bleeding rates for antiplatelets and anticoagulants
3. Relationship between frequency of patients receiving appropriate dosage of DOACs according to renal function and bleeding rates after PTGBD in patients receiving DOACs
Observational
| 18 | years-old | < |
| Not applicable |
Male and Female
Patients over 18 years-old at the time of entry
Patients with indication of PTGBD for acute cholecystitis
Patients with no antithrombotic drug use or receiving a single antithrombotic drug before PTGBD
Patients who have provided written consent for participation
Patients receiving multiple antithrombotic drugs
Patients who cannot consent to participate
Patients judged by study investigator/sub-investigators as inappropriate ones
500
| 1st name | Hayato |
| Middle name | |
| Last name | Hikita |
Osaka University Graduate School of Medicine
Gastroenterology and Hepatology
5650871
Yamada-oka 2-2, Suita, Osaka, Japan
0668793621
takehara@gh.med.osaka-u.ac.jp
| 1st name | Teppei |
| Middle name | |
| Last name | Yoshioka |
Osaka University Graduate School of medicine
Gastroenterology and Hepatology
5650871
Yamada-oka 2-2, Suita, Osaka, Japan
0668793621
teyoshioka@gh.med.osaka-u.ac.jp
Osaka University Graduate School of Medicine
Hikita Hayato
Osaka University Graduate School of Medicine, department of Gastroenterology
Self funding
Osaka University Hospital Institutional Review Board
Yamadaoka 2-2, Suita, Osaka, Japan
06-6210-8289
rinri@hp-crc.med.osaka-u.ac.jp
NO
| 2024 | Year | 07 | Month | 01 | Day |
Unpublished
Open public recruiting
| 2024 | Year | 03 | Month | 28 | Day |
| 2024 | Year | 06 | Month | 04 | Day |
| 2024 | Year | 08 | Month | 01 | Day |
| 2029 | Year | 12 | Month | 31 | Day |
prospective observational study
| 2024 | Year | 06 | Month | 05 | Day |
| 2025 | Year | 07 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062370